Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy

Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy

Objective:Polypharmacy brings with it the risk of potential drug interaction. This study aimed to investigate polypharmacy, potential drug interactions, the drug interactions causing neurological symptoms in geriatric patients with epilepsy, and diffenrences between drug interaction databases.Method...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Bahar Erbaş
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Galenos Yayinevi 2022-09-01
Sraith:	Archives of Epilepsy
Ábhair:	drug interactions epilepsy polypharmacy
Rochtain ar líne:	http://archepilepsy.org/archives/archive-detail/article-preview/polypharmacy-and-potential-drug-nteractions-causin/54573

Míreanna comhchosúla

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
de réir: Ivan Krečak, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Polypharmacy and potential drug–drug interactions in patients with rheumatoid arthritis
de réir: Zakaria M Al-Ghazaly, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
de réir: Adetola Olaniyi Bojuwoye, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population
de réir: Carla Bastida, et al.
Foilsithe / Cruthaithe: (2017-09-01)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
de réir: Akshay Khandeparkar, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
de réir: Bianca Papotti, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Frequency of polypharmacy and drug interactions in inpatients in the emergency department, Southwest of Iran
de réir: Mobina Tahmasebivand, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Evaluation of Polypharmacy and Drug Interactions in the Treatment of Patients with Sepsis
de réir: Nursel Sürmelioğlu, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
de réir: Marwan Sheikh-Taha, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Rationale, design, and methodology of the EPIC (Epidemiology of Polypharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients) study
de réir: Eda Özlek, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Drug utilization pattern and factors associated with polypharmacy and excessive polypharmacy in geriatric medical out-patients at a rural health training centre in India
de réir: S Nitya, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Polypharmacy: An Overview
de réir: Nelisa Paidamwoyo Ganga
Foilsithe / Cruthaithe: (2022-12-01)

Overview of Polypharmacy and Drug Interactions in Chronic Kidney Disease Patients at Siloam Hospitals Lippo Village
de réir: Anastasia Pramitaningastuti
Foilsithe / Cruthaithe: (2024-04-01)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
de réir: Dario Cattaneo, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
de réir: Assefa YA, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors
de réir: Rita F. Oliveira, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Polypharmacy in Older Adults with Alzheimer’s Disease
de réir: Satoru Esumi, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Screening indicators to evaluate the clinical significance of drug-drug interactions in polypharmacy among older adults with psychiatric disorders: a delphi study
de réir: Yu Liu, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
de réir: Paula Bachmann, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Pharmacist interventions for older adults with polypharmacy in an ambulatory geriatric clinic
de réir: Antonietta Paneccasio, et al.
Foilsithe / Cruthaithe: (2025-12-01)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic
de réir: Dario Cattaneo, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
de réir: Juveriya Farooq, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Survey of polypharmacy prescription in a tertiary care Hospital, Belagavi
de réir: Suma Sukumaran, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Polypharmacy in Older Adults (Out of Print)
de réir: Eric Orton
Foilsithe / Cruthaithe: (2007-01-01)

Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential
de réir: Mauro Cataldi, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Potential drug-drug interactions in hospitalized patients with COVID-19.
de réir: Danuta Szkutnik-Fiedler, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Nurses Opinion on the Attributes of Polypharmacy in Patient Safety
de réir: John Lisha Jenny, et al.
Foilsithe / Cruthaithe: (2012-07-01)

Nurses Opinion on the Attributes of Polypharmacy in Patient Safety
de réir: Fathi Mohamed Mohamed, et al.
Foilsithe / Cruthaithe: (2012-07-01)

Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
de réir: Adem L, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic
de réir: Adriana Matos, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Polypharmacy in the elderly
de réir: Negar Golchin, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Evaluation of Potential Drug - Drug Interactions in General Medicine Ward of Teaching Hospital in Southern India
de réir: Akram Ahmad, et al.
Foilsithe / Cruthaithe: (2015-02-01)

Assessment of Potential Drug-drug Interactions among Ischaemic Stroke Patients in a Charitable Hospital
de réir: Amala Johnson, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Polypharmacy in Osteoporosis Patients
de réir: Yavuz Ali Karahan, et al.
Foilsithe / Cruthaithe: (2015-04-01)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
de réir: Norio Yasui‐Furukori, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Polypharmacy and potential inappropriate drug use in the elderly admitted to the general internal medicine outpatient clinic
de réir: Celaleddin Demircan, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Polypharmacy among adults aged over 65 years
de réir: Patrycja Misztal-Okońska, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy
de réir: Ursula Wolf, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Polypharmacy, potentially serious clinically relevant drug‐drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life
de réir: Labib AL‐Musawe, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
de réir: Tommaso Sciarra, et al.
Foilsithe / Cruthaithe: (2019-09-01)